This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Sheba Medical Center.
Recruitment status was:  Recruiting
Information provided by:
Sheba Medical Center Identifier:
First received: December 24, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted

sudden sensorineural hearing loss:

  • idiopathic in most cases
  • 5-20/100,000 new cases annually in the U.S
  • no establishes pathogenesis
  • treated with oral steroids in most cases
  • ~50% improvement in hearing levels
  • bed rest - acceptable treatment, not well investigated

Condition Intervention Phase
Sudden Loss of Hearing Procedure: bed rest Drug: prednisone - oral corticosteroid 1mg/kg/D for 1 week Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss

Resource links provided by NLM:

Further study details as provided by Sheba Medical Center:

Primary Outcome Measures:
  • hearing improvement

Estimated Enrollment: 60
Study Start Date: June 2006
Estimated Study Completion Date: December 2008

Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients with sudden sensorineural hearing loss

Exclusion Criteria:

  • age less than 16 years
  • contraindication for oral steroid treatment
  • prior steroid treatment for hearing loss
  • pregnent women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00416143

Contact: Eldar Carmel, MD 972-3-5302442

Sheba Medical Center Recruiting
Tel Hashomer, Israel
Contact: Eldar Carmel, MD    972-3-5302442   
Principal Investigator: Eldar Carmel, MD         
Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Eldar Carmel, MD Sheba Medical Center
  More Information Identifier: NCT00416143     History of Changes
Other Study ID Numbers: SHEBA-06-4065-EC-CTIL
Study First Received: December 24, 2006
Last Updated: December 24, 2006

Keywords provided by Sheba Medical Center:
Bed rest for idiopathic sudden sensorineural hearing loss

Additional relevant MeSH terms:
Hearing Loss
Hearing Loss, Sensorineural
Hearing Loss, Sudden
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Anti-Inflammatory Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Antineoplastic Agents, Hormonal
Antineoplastic Agents processed this record on September 20, 2017